Deepak Srivastava, MD, director of the Gladstone Institute of Cardiovascular Disease, has received the prestigious 2007 E. Mead Johnson Award from the Society for Pediatric Research. Bestowed annually ...

J. David Gladstone Institutes President Robert W. Mahley, MD, PhD, today announced the appointment of Deepak Srivastava, MD, as the new director of the Gladstone Institute of Cardiovascular Disease ...

“I see a future where we’ll be using today’s advances in genetics, artificial intelligence, and other scientific fields to quickly identify and actually cure diseases,” Srivastava says. “It’s ...

Scientists are making headway in exploring the potential future use of stem cells to treat heart disease, according to a review article in the current issue of Nature (June 29, 2006). Authored by ...

Three UCSF scientists have received grants from the California Institute for Regenerative Medicine (CIRM) to advance their investigations of treatment strategies for degenerative muscle diseases, such ...

The first pill shown to treat COVID-19 has moved one step closer to being available to the public. The pharmaceutical company Merck requested FDA emergency authorization Monday for their COVID-19 ...

SAN FRANCISCO, CA –May 7, 2007—The Gladstone Institute of Cardiovascular Disease (GICD) announced today that GICD Director, Deepak Srivastava has received the 2007 prestigious E. Mead Johnson Award ...

SAN FRANCISCO (KGO) -- The Journal of the American Medical Association published a research letter suggesting high levels of carbon dioxide detected in children wearing masks. "There may be some ...

San Francisco, CA - Dr Deepak Srivastava has been appointed as the new director of the Gladstone Institute of Cardiovascular Disease (GICD) in San Francisco. Srivastava is currently a professor in the ...